Natural Alternativ (NAII) 10.66 $NAII Natural

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Natural Alternativ (NAII) 10.66 $NAII

Natural Alternatives posts 3Q profit
Automated Insights - Tue May 10, 5:40PM CDT
SAN MARCOS, Calif. (AP) _ Natural Alternatives International Inc. (NAII) on Tuesday reported fiscal third-quarter net income of $3 million.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Announces Fiscal 2016 Q3 Results
PR Newswire - Tue May 10, 3:30PM CDT
Natural Alternatives International, Inc. ("NAI" (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $3.0 million, or $0.46 per diluted share, on net sales of $30.0 million for the quarter ended March 31, 2016. Quarterly results were favorably impacted by the sale of our domestic corporate headquarters in San Marcos, CA, that resulted in a one-time gain on the sale, net of tax, equal to $1.0 million, or $0.15 per diluted share. Excluding this transaction, our net income from recurring business during the third quarter of fiscal 2016 was $2.0 million, or $0.31 per diluted share.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Announces Issuance of New U.S. Beta-alanine Patent
PR Newswire - Fri Apr 15, 1:30PM CDT
Natural Alternatives International, Inc. ("NAI" (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. RE45,947 entitled "Methods and compositions for increasing the anaerobic working capacity in tissues." The newly reissued patent becomes part of NAI's global patent estate covering its CarnoSyn® beta-alanine product.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Settles Patent Infringement Claims Against Woodbolt
PR Newswire - Mon Mar 21, 11:50AM CDT
Natural Alternatives International, Inc. ("NAI" (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements and the supplier of CarnoSyn® beta-alanine, announced today that it has settled the patent litigation pending in U.S. District Court for the Southern District of Texas between NAI and Woodbolt Distribution, LLC over NAI's beta-alanine patents. NAI has granted Woodbolt a license to the beta-alanine patents at issue in the litigation and others in its patent portfolio. Other settlement terms were confidential.
NAII: 10.66 (+0.44)

Natural Alternatives International achieves higher net income of USD1.2m for Q1 fiscal 2016
M2 - Fri Nov 13, 4:45AM CST
Nutritional supplements company Natural Alternatives International (NasdaqGM:NAII) stated on Thursday that its net income was USD1.2m (USD0.18 per diluted share) for the quarter ended September 30, 2015.
NAII: 10.66 (+0.44)

BUYINS.NET: NAII SqueezeTrigger Price is $6.22. There is $44,622 That Short Sellers Still Need To Cover.
M2 - Thu Oct 22, 12:09PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Natural Alternatives International Inc (NASDAQ:NAII) in real time and just received an alert that NAII is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 6700 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.22. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Announces Expanded Commitment to the CarnoSyn® Brand and Previews SR CarnoSyn® Sustained Release Product Formulation
PR Newswire - Wed Oct 07, 12:25PM CDT
Natural Alternatives International, Inc. (NAI) (NASDAQ: NAII), a global formulator and manufacturer of customized nutritional supplements, announced its expanded commitment to CarnoSyn®, a studied, patent-protected beta-alanine ingredient for supporting an increase in muscle carnosine and athletic performance. As part of its commitment, NAI began to directly oversee the sales and distribution of CarnoSyn® in the United States and abroad as of April 1st, 2015. NAI is showcasing CarnoSyn® and previewing SR CarnoSyn® - a new sustained release beta-alanine powder - at the upcoming SupplySide West conference in Las Vegas, Nevada on October 5-9, 2015.
NAII: 10.66 (+0.44)

BUYINS.NET: NAII SqueezeTrigger Price is $6.22. There is $57,057 That Short Sellers Still Need To Cover.
M2 - Wed Oct 07, 3:55AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Natural Alternatives International Inc (NASDAQ:NAII) in real time and just received an alert that NAII is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 9100 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.22. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
NAII: 10.66 (+0.44)

Natural Alternatives International announces new promotions
M2 - Fri Oct 02, 6:11AM CDT
Nutritional supplements company Natural Alternatives International (NasdaqGM:NAII) reported on Thursday that it has appointed Kenneth Wolf as its president.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Promotes President and Chief Financial Officer
PR Newswire - Thu Oct 01, 3:15PM CDT
Natural Alternatives International, Inc. ("NAI" (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the promotions of Kenneth Wolf to President and Michael Fortin to Chief Financial Officer.
NAII: 10.66 (+0.44)

BUYINS.NET: NAII SqueezeTrigger Price is $6.22. There is $53,256 That Short Sellers Still Need To Cover.
M2 - Thu Oct 01, 3:34AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Natural Alternatives International Inc (NASDAQ:NAII) in real time and just received an alert that NAII is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 8400 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $6.22. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
NAII: 10.66 (+0.44)

Natural Alternatives International posts higher net income of USD3.3m for fiscal 2015
M2 - Mon Sep 21, 3:05AM CDT
Nutritional supplements company Natural Alternatives International (NasdaqGM:NAII) stated on Friday that it recorded net income of USD3.3m (USD0.49 per diluted share) for the fiscal year ended June 30, 2015.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Files Unfair Competition, False Advertising and Disparagement Complaint Against Creative Compounds Inc.
PR Newswire - Fri Sep 18, 2:33PM CDT
Natural Alternatives International, Inc. ("NAI" (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that it has filed a Complaint against Creative Compounds Inc. ("Creative" to stop Creative from intentionally and improperly trying to mislead NAI's actual and potential customers and wrongfully interfering with NAI's CarnoSyn® beta-alanine business. The suit was filed in U.S. District Court for the Southern District of California.
NAII: 10.66 (+0.44)

Natural Alternatives International, Inc. Announces Fiscal 2015 Results
PR Newswire - Fri Sep 18, 2:20PM CDT
Natural Alternatives International, Inc. ("NAI" (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.49 per diluted share, on net sales of $79.5 million for the fiscal year ended June 30, 2015.
NAII: 10.66 (+0.44)

Gordagen Appoints Natural Alternatives International Inc. as US Manufacturing Partner
GlobeNewswire - Tue Sep 15, 7:30AM CDT
Gordagen Pharmaceuticals, an Australian private company commercializing evidence-based nutraceuticals and pharmaceuticals based on tocotrienols, today announced the appointment of Natural Alternatives International, Inc. (NAI) in San Marcos, California to manufacture its nutraceutical products for the US market.
NAII: 10.66 (+0.44)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 9

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Samer Alkhaldi Joins HFM to Drive Business Growth in MENA Region

Updated Category News Views 65

Samer Alkhaldi Takes Charge at HFM for MENA Development In an exciting development for HFM, a prominent player in global online trading, Samer Alkhaldi has been appointed as the new Regional Head of Business Development for the MENA region. With an extensive background in the financial sector, Samer’s appointment is a significant strategy to expand and improve services...

Continue Reading
Kenyan Government's Strategic Shift Towards Digital Operations

Updated Category News Views 286

Kenya's Digital Transformation with Danish F2 Platform The Kenyan government is embarking on an exciting journey towards digital transformation by adopting the Danish F2 platform. This innovative initiative was shared by the Ministry of Information, Communications, and the Digital Economy, aiming to streamline processes across various governmental departments. Objective...

Continue Reading
Brookfield Corporation Plans Upcoming Investor Day Event

Updated Category News Views 210

Brookfield Corporation's Investor Day Announcement Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) are gearing up for a significant Investor Day scheduled for a Wednesday in New York. This event aims to engage investors with insights on the company's strategic direction and performance metrics. Event Details The...

Continue Reading
Virtune Updates on MarketVector's Pricing Changes for ETPs

Updated Category News Views 155

Virtune Announces Important Pricing Update for ETPs Virtune, a leading player in digital asset management, has shared significant news regarding its approach to the pricing of its exchange-traded products (ETPs). Effective December 4, 2025, the company will update its reference price provider MarketVector, switching the underlying price source for its crypto assets used...

Continue Reading
Accessible Healthcare Support for Wildfire Affected Residents

Updated Category News Views 157

Virtual Healthcare Appointments for Affected Residents In light of the recent wildfires in Southern California, those who have faced displacement or adversity due to these events can now access more no-cost virtual healthcare appointments. This initiative is expanding to ensure that residents in Los Angeles can receive urgent medical attention, including vital services...

Continue Reading